Mati Kargren

[ Collaborative presentation on nerve regeneration using Schwann cells. ] At the 35th Annual Meeting of the Japanese Peripheral Nerve Society Research to be held on September 6-7, we will make a presentation on “Production of Schwann cells that can be expected to promote nerve regeneration using human pluripotent stem cells”. In addition, a collaborative research partner, the Department of Orthopedics, Kyoto University Hospital, will make a presentation on the effects of transplantation of the SCAD’s Schwann cells on nerve regeneration in a rat peripheral nerve injury model. These research results will be the basic functionality and effectiveness for the development of treatments for various types of nerve damage using SCAD’s Schwann cells. https://lnkd.in/eybiPHbn

2

Taiwan Life Sciences Biweekly - Aug. 05, 2024 📣 JelloX Biotech collaborates with Mayo Clinic to develop AI enhanced 3D pathology imaging technology 📣 Allergen testing company Excelsior Bio-System's animal testing products enter South Korea market 📣 Gongwin BioPharm's pet cancer medication a step closer to market entry, expects to obtain a drug license in the first half of 2025. 📣 BIO Asia-Taiwan 2024 concludes successfully on Monday, with the dates for next year's event announced; BIO Asia-Taiwan 2025 will be held in Taipei on July 23-27. BIO Asia-Taiwan this year had about 900 exhibitors, with the number of booths exceeding 2,200. Event participants booked more than 8,000 one-on-one business meetings, an increase of 70 percent year-on-year. The number of visitors to the full schedule of events including the exhibition 120,000, setting another new record. On the first day of the conference, more than 2,000 people participated, 40 percent of whom were from abroad, with Japan, the United States, and South Korea making up the largest number of participants. 📣 The Small and Medium Enterprise and Startup Administration under the Ministry of Economic Affairs and Taipei City-based American State Offices Association jointly organized a biotechnology and medical care forum July 26 in Taipei City to explore future cooperation opportunities between Taiwan and the U.S. 📣 The Taiwan Nongovermental Hospitals and Clinics Association and the Biosimilars Committee of the Taiwan Bio Industry Organization (Taiwan BIO) jointly organized a summit entitled 'Advanced Biosimilar Usage in Taiwan: Global Insights and Local Strategies', one of the official Satellite Symposia of BIO Asia-Taiwan this year. 📣Taiwan Bio-Manufacturing Corporation (TBMC) announced at BIO Asia-Taiwan 2024, that the company had formed an alliance with CMIC Bio, Japan's largest commissioned clinical research (CRO) company, and Thermo Fisher Scientific of the United States. Together with its strategic partner Resilience of the United States, TBMC intends to continue to make inroads into the international CDMO market. 📣 Super-aged Precision Regenerative Medicine Project unveils midterm results, the teams include Taipei City-based Academia Sinica, National Taiwan University and Yang Ming Chiao Tung University, New Taipei City-based Far Eastern Memorial Hospital, Taoyuan City-based Chang Gung University, Taichung City-based China Medical University and Tainan City-based National Cheng Kung University. 📣 Taiwan BIO organized 2024 Taiwan BIO Awards category winners were announced today. A total of 19 institutions and product technologies were selected. 📣The Department of Industrial Technology of the Ministry of Economic Affairs (MOEA) held a press conference at BIO Asia-Taiwan 2024 and announced two major local developments in cancer medical research. For more details: https://lnkd.in/gfrr3Bg8

1

The Taiwan Biobank is the oldest and arguably most comprehensive biobank in Taiwan. Established in 2012 at Academia Sinica, its goal is to accelerate scientific discovery by providing researchers access to resources for biomedical research. The TWB’s main resource is its population cohort, which is comprised of 200,000 participants recruited from different parts of Taiwan, with most participants being between the age of 30-70. All participants have signed a broad informed consent with the choice of allowing linkage of their #biobank data with other health-related databases from the government. To learn more: https://lnkd.in/dMhX8Wzi #Biobanking #Biorepository #Cryopreservation #TaiwanBiobank #Taiwan #Databank #Database #Biospecimens #Storage #Data #Biopreservation #Medical #Research International Health Cohorts Consortium (IHCC) | Chung-ke Chang | Academia Sinica, Taiwan

20

🔬 Exciting Research Discovery Alert! In a groundbreaking study, researchers have uncovered the pivotal role of lactobacilli in maintaining immune balance. Using the innovative "ASF" microbiota, containing a blend of two lactobacilli strains and six other lactobacilli strains, animal experiments revealed fascinating insights. Did you know that lactobacilli influence the concentration of a vital immune mediator called "interferon gamma"? Produced by lymphocytes, this mediator is a powerhouse in our defense against viruses, activating phagocytes and inducing crucial antigen expression. But here's the kicker: when experimental mice lacked lactobacilli in their intestines, symptoms of depression and anxiety intensified. Conversely, elevating lactobacilli levels in the gut helped regulate the mice's stress response, hinting at a promising trend towards reversing depression. This study underscores the profound impact of gut microbiota on mental health and highlights lactobacilli as potential players in therapeutic interventions. Stay tuned for more groundbreaking discoveries in the fascinating world of microbiome research! 🌱 💡 #Microbiome #HealthDiscovery #LactobacilliInAction

2

📌 The CityU-AFCR Symposium on Precision Medicine and Digital Medicine was held on September 12-13 at the Hong Kong Convention and Exhibition Centre, as part of BIOHK2024. The event featured presentations from leading experts in precision medicine, creating a dynamic platform for exchanging innovative ideas and fostering collaboration in the biotechnology field. City University of Hong Kong Asian Fund for Cancer Research #BIOHK2024 #PrecisionMedicine #DigitalMedicine #Cancer #MedNews #Health #Medicine #MedTwitter #OncoDaily #Oncology

21

💡 👨‍🔬 Breakthrough Multi-Cancer Early Detection Research Findings at Prestigious American Society of Clinical Oncology (ASCO) Annual Meeting 2024 in Chicago 🌎 Dr. Le Son Tran, the SPOT-MAS R&D Team leader from Medical Genetics Institute Ho Chi Minh City and Gene Solutions is set to present breakthrough findings at the upcoming prestigious oncology conference this weekend. Since 2022, Gene Solutions kicked off the largest and most comprehensive multi-center prospective study, K-DETEK, to clinically validate the diagnostic performance of SPOT-MAS - recruiting 10,027 asymptomatic individuals aged 40 years or older. Our team is looking forward to share our findings at our poster session. The MCED team at Medical Genetics Institute Ho Chi Minh City and Gene Solutions developed a novel approach - Screening for the Presence Of Tumor by Methylation And Size (SPOT-MAS), which offers a comprehensive analysis through the integration of methylation, fragment length profile, DNA copy number aberration and end motif in a single library reaction. It was designed to simultaneously detect five common types of cancer, including liver, breast, colorectal, gastric, and lung cancer, and predict the tissue origin of cancer signal. Read more about our K-DETEK study abstract here: https://lnkd.in/gjNd9unN Future of Oncology: The strong performance of the K-DETEK study underpins the potential to shape the future direction of oncology research and treatment. The research team welcomes collaborative opportunities and anticipates our participation at ASCO Annual Meeting will provide a platform for collaboration among top oncology professionals. The conference will run from May 31 to June 4, at McCormick Place, Chicago USA and is also available online. It is an opportunity not to be missed for anyone interested in the forefront of cancer research. Our team is happy to meet up at ASCO in person - please DM us if you are keen to connect, or join us at our poster session: https://lnkd.in/gk83xwjG #MCED #SPOTMAS #KDETEK #earlydetectionsaveslives

92

1 則回應

[info] Korea Drug Development Fund (KDDF) is investing next-generation anticancer drugs The Korea Drug Development Fund (KDDF) is the largest #publicfund of #drug #researchanddevelopment (R&D) in Korea and it provides R&D grants to approximately 100 new companies every year to help them translate early-stage drug discovery to clinical development with more than $150 million per year. Three companies are currently working on novel cancer therapies: 1. PRIMEBIO : blocking cancer stemness with PMB212 2. AbTis Co.,Ltd. : antibody–drug conjugate (#ADC) #linkers 3. CellBion : pioneering #radioligand therapies Check more details of the companies’ technologies 👇

12

🧬 Engineering the Future of Bacterial Therapy with LNPs! 🦠💡 Kudos to the Korea Research Institute of Bioscience and Biotechnology for their pioneering study, "Lipid Nanoparticle-Mediated CRISPR-Cas13a Delivery for the Control of Bacterial Infection." 📊 Summary and Conclusions This research introduces a method for delivering CRISPR-Cas13a using lipid nanoparticles (LNPs). By screening 511 LNP formulations, the team identified optimal candidates that efficiently transported plasmid DNA into Gram-negative bacteria, overcoming challenges in membrane permeability with innovative “LNP-helpers.” This method successfully controlled bacterial infections in preclinical models, offering a glimpse into how gene-editing tools could reshape antibacterial therapies. 🌐 Read the full paper here: https://lnkd.in/gjD-CtFY BroadPharm is proud to support this research with ionizable, cationic, and helper lipids like 306Oi10, DOTMA, ALC-0159, and others crucial in preparing and analyzing these LNPs. Discover our advanced lipid catalog and empower your drug delivery research with BroadPharm’s lipid solutions: 🔗 306Oi10 —> https://lnkd.in/gvD7ETKW 🔗 DOTMA —> https://lnkd.in/g8Hh8AYB 🔗 ALC-0159 —> https://lnkd.in/g3xYDh4x 🔗 Ionizable Lipids —> https://lnkd.in/gG6AcbSe 🔗 Cationic Lipids —> https://lnkd.in/gU4ec2Z2 🔗 Helper Lipids —> https://lnkd.in/gc6Wmmaz

5

1 則回應

Looking forward for the coming podcast! ETAST hosted a workshop last year in Dortmund which helped me a lot building on #CV, #interview concepts and #academia_career development, especially tips and experience sharing directly from people. I believe this workshop is boosting my career forward to the positive direction. It's good to know with podcast these fantastic helps I got before will have chance to be delivered to much more #Taiwanese_researchers_in_Europe.

5

https://lnkd.in/gvHVCMmR   Article title: Relationship between Il28b Gene Polymorphisms and the Risk of Hepatocellular Carcinoma Development within Vietnamese Hepatitis B Virus Carriers   Author(S): Ngo Tat Trung, Dao Phuong Giang, Dao Thanh Quyen, Mai Thanh Binh, Mai Hong Bang, Nguyen Linh Toan, Phan Quoc Hoan and Le Huu Song*   Journal: Journal of Clinical Microbiology and Biochemical Technology   Journal ISSN: 2581-527X Abstract: IL28B’s SNPs are considered the most important host factors predicting the success of Peg-INF alpha/ribavirin based regimens against Hepatitis C virus (HCV) infection. However, the associations of HBV mediated etiologies have not been well documented. This study investigated the relationship between the three most clinically relevant IL28B SNPs (rs8099917, rs12980275, and rs12979860) with the risk of HBV/HCV infection and HCC development within Vietnamese HBV carriers. By using kinetics and allele specific real-time PCR, the study demonstrated holders of the T/G allele at SNP rs8099917 were less susceptible to HBV/HCV infection. Notably, HBV carriers with the SNP rs8099917 T/G allele were at lower risk of being transformed into HCC. However, because of a small sample size, statistical analysis did not reach significance to demonstrate an association between frequencies of IL28B SNPs and HBV mediated HCC development, even though only the minor allele carriers (either 4 G/G cases of rs8099917 or one T/T case of rs12979860) were recorded in the HCC group. #HBV #HCV #HCC #IL28B #Allelefrequencies   #CellularMicrobiology #EnvironmentalMicrobiology #MedicalMicrobiology #IndustrialMicrobiology #MarineMicrobiology #AquacultureMicrobiology #Bacteriology #Chlamydiology #Rickettsiology #Peertechz #PeertechzPublications #Mycobacteriology #AerobicActinomycetes #Mycology #Parasitology #Virology #ClinicalVeterinaryMicrobiology #Epidemiology #Biochemical #Endocytosis #Exocytosis #MembraneBiology #CellMigration #CellMatrix #OrganelleBiogenesis #Cytoskeleton #Proteolysis #CellDeath #CellCycle #CancerResearch #CellGrowth #CellDeath #CellDifferentiation #DrugTargets #GeneTherapy #DiseaseModels #Proteomics #StemCells #Bioenergetics #Mitochondria #FreeRadicals #RedoxSignaling #IonTransport #OxidativeStress #CellularMetabolism #XenobioticMetabolism #Metabolomics #CircadianControls #Hormones #Photosynthesis #CellSignaling #NitrogenFixation #PlantDisease #TransportProcesses #PlastidSystems #CellWallSynthesis #Phosphorylation #ProteinKinases #Phosphates #Ubiquitination #LipidSignaling #SecondMessengers #Cytokines #Receptors #GrowthFactors #GProteins #Integrins #NitricOxide #Enzymology #MolecularMechanisms #Biophysics #BiomolecularAssociations #SystemsBiology #ChemicalBiology #ProteinStructure #NucleicAcids #AminoAcids #DrugDesign #BiomolecularTargets #Lipids #Carbohydrates

1

【1st in HK and Asia】In the "2024 Global Ranking of Academic Subjects (GRAS)", CU Medicine ranks 1st in Asia and 14th globally in "Clinical Medicine" by ShanghaiRanking. In the field of "Nursing", the Nethersole School of Nursing ranks 2nd in Asia and 23rd in the world. CU Medicine ranks 1st in both Clinical Medicine and Nursing in Hong Kong. Professor Philip CHIU, Dean of CU Medicine, remarked, “The achievement of CUHK’s Faculty of Medicine in this international ranking is the result of the joint efforts of the entire Faculty, demonstrating that the quality of our teaching and research in healthcare has been recognised globally. We will continue to nurture more capable and compassionate healthcare professionals for the benefits of the patients and community.” ShanghaiRanking's Academic Ranking of World Universities (ARWU) is one of the most prominent global rankings of the world’s top universities. The 2024 GRAS contains rankings of universities in 55 subjects across Natural Sciences, Engineering, Life Sciences, Medical Sciences, and Social Sciences. More than 1,900 out of 5,000 universities across 96 countries and regions are listed in the rankings this year. The GRAS rankings use a range of objective academic indicators and third-party data to measure the performance of world universities in respective subjects, covering 5 major evaluation categories such as world-class faculty, world-class output, high-quality research, research impact and international collaboration. The index of international academic awards is based on Academic Excellence Survey (AES) conducted by ShanghaiRanking. Details of the Ranking: https://bit.ly/3CmEp0v #CUMedicine #GRAS #ARWU #Ranking

175

6 則回應

"Proud to have participated in the EduCare Taiwan webinar on 'Latest Research on Structures and Mechanisms Underlying Human Diseases & Targeting Treatment for Advanced Cancers.' A great opportunity to learn about cutting-edge developments in cancer research! #LearningNeverStops #CancerResearch #EduCareTaiwan #ContinuousEducation"

4

TAIWAN MAKES QUEER HISTORY 🌈 In January, Huang Jie made history in Taiwan as the first openly gay legislator elected in the city's sixth constituency. The 30-year-old Huang secured 113,670 votes (51.01% of the vote), defeating her main rival, Chen Mei-ya, a five-term city councilor, who received 93,750 votes (42.07%). Huang Jie is a member of the Democratic Progressive Party (DPP). In April 2023, she publicly shared her coming-out experience, revealing that she hadn't initially come out when starting her political career. However, after doing so, some voters expressed that she had given them courage. Despite facing attacks during her campaign for being gay, Huang says she is committed to advancing equality in Taiwan's society. Her significant re-election as an independent city councilor in 2022, with 27,744 votes, showcases her widespread support in southern Taiwan. I believe Huang's achievement is noteworthy for two reasons. Firstly, it addresses the crucial issue of queer representation and visibility. Having competent lawmakers who openly identify as queer is critical for drafting effective queer-centric public policy. Secondly, as a lawmaker, Huang now holds the power to directly influence policy change. City councilors play a vital role in monitoring city affairs, managing budgets, and giving structure to public opinions. Huang's new role empowers her to make her constituency more inclusive for the queer community, backed by the people's mandate. This is a significant step towards breaking down barriers and promoting equality in Taiwanese policymaking. #QueerRepresentation #PolicyChange #TaiwanEquality #HuangJie

2

🌏 Now is the Perfect Time to Conduct Clinical Trials in Korea! 🌟 The Korean won depreciation offers foreign biotech and pharmaceutical companies an extraordinary opportunity to significantly reduce clinical trial costs in Korea. 💡 📍 Why Korea? 1️⃣ Cost Efficiency at Its Best: Researcher fees, clinical management costs, central laboratory services, and subscriptions to various clinical trial solutions are now more affordable than ever. 2️⃣ World-Class Infrastructure: Benefit from Korea's rapid approval processes and globally recognized data management systems for high-quality outcomes. 3️⃣ Access to Diverse Patient Data: Obtain cost-effective data that reflects Asia's genetic and environmental diversity. 📊 By partnering with leading CROs in Korea, your clinical trials can achieve not only cost savings but also deliver top-tier results. We offer tailored solutions and optimized services to meet your needs. 💻 Additionally, leverage cutting-edge IT solutions, advanced imaging data services, and high-quality central laboratory management. ✨ Contact us today! Capitalize on the favorable exchange rates and position your research for success. Korea is ready to collaborate with you and help drive your clinical trial results to the next level. Let's build the future of global clinical trials together! #ClinicalTrials #CRO

6

📚 Ho JC, Chai HH, Lo EC, Huang MZ, Chu CH. Strategies for Effective Dentist-Patient Communication: A Literature Review. Patient preference and adherence. 2024 Dec 31:1385-94. URL: https://lnkd.in/g_uAgECj 📊 Key Takeaways: - Effective dentist-patient communication is crucial for quality dental care 🦷 - Communication should be clear, correct, concise, complete, and cohesive 🗣️ - Both verbal and non-verbal communication play important roles 👥 🔑 Strategies for Effective Communication: - Listen attentively to patients 👂 - Use clear and simple language 🗨️ - Encourage questions and feedback 🤔 - Utilize visual aids 📊 - Provide reassurance and empathy 🤗 - Take a patient-centered approach 🧑‍⚕️ - Show positive body language 👐 - Follow up with patients 📞 - Use information technology wisely 💻 ✅ Action Points for Educators: - Integrate communication skills training into dental curricula 📚 - Emphasize the importance of non-verbal communication 👀 - Teach strategies for managing patient anxiety and building trust 😌 - Incorporate role-playing exercises to practice communication skills 🎭 🔮 Future Directions: - Develop standardized assessment tools for communication skills 📋 - Explore the impact of cultural competence on dentist-patient communication 🌍 - Investigate the effectiveness of teledentistry in improving patient communication 📱 - Research the long-term effects of improved communication on patient outcomes 📈 #DentalEducation #PatientCommunication #ContinuingEducation #HealthcareCommunication #CommunicationSkills

16

2 則回應

Advancing Healthcare Through Nanotechnology-Based Biosensors Driven by a passion for biomedical innovation, Bangladeshi student Masrur Md Alam is pursuing a PhD in Biomedical Engineering at CUHK. Under the supervision of Professor Zhaoli GAO, his current research at the Molecular Diagnostics Laboratory focuses on developing a carbon nanotube-based gas sensor, or “electronic nose”, integrated with artificial intelligence. This innovative approach aims to contribute to the advancement of non-invasive diagnostic pathways for early disease detection and personalised healthcare management. By combining cutting-edge carbon nanotube gas sensor technology and AI-powered data analysis, Masruck hopes to establish reliable, comfortable and cost-effective alternatives to traditional medical procedures. Learn more about the CUHK's MPhil-PhD in Biomedical Engineering: https://bit.ly/45Qe59H CUHK Faculty of Engineering #CUHK #thechineseuniversityofhongkong #CUHKGraduateSchool #CUHKEngineering #ResearchExcellence #CUHKResearch #BiomedicalEngineering #Nanotechnology #Biosensor #AI #MedicalDiagnostics #ResearchInnovation

16

(English follows) Session 2: Second Plenary- Updates from CDISC 2つ目のトピックはCDISC Christine Connolly　　より「Digital Health Technologies (DHTs): A Path to Data Standardization」. CDISCのigital Health Technologies Initiativeの活動についてご説明いただきました。データの動きもどんどん変わっていくのですね。 #cdisc2024japan #cdisc #japan #interchange #aoyama #tokyo #japan #cleardataclearimpact #DHT #digitalhealthyechnologies #dime #digitalmedicinesociety Session 2: Second Plenary- Updates from CDISC The second topic was "Digital Health Technologies (DHTs): A Path to Data Standardization" by Christine Connolly Head of Standards Projects for CDISC. We received an explanation about the activities of CDISC's Digital Health Technologies Initiative. The movement of data is also changing rapidly.

40

1 則回應

In a study published in Cell on May 22, researchers led by Prof. Li Chuanyou from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences report their discovery that REGENERATION FACTOR1 (REF1) is the primary local wound signal that instigates plant regenerative responses. This discovery suggests a convenient method for improving the transformation efficiency of difficult-to-transform crops by boosting their regeneration capacity. Upon injury, plants immediately activate defense responses to prevent pathogen infection and/or insect attack. In parallel, plants activate cellular reprogramming to repair damaged tissues and regenerate lost body parts. While the wound signals and signaling cascades used by plants to activate wound-induced defense responses are well understood, the molecular mechanisms underlying wound-induced regenerative responses remain obscure. Although wounding is essential for initiating various types of organ regeneration, the biochemical nature of the putative local wound signals governing this process has remained a mystery for centuries. Furthermore, the regenerative capacity of plants in nature varies widely among species and genotypes, which is one of the major hurdles to fully realizing the potential of genetic transformation and genome editing technologies for crop breeding. Therefore, among 125 important unanswered questions listed by the journal Science, "What controls organ regeneration?" was selected as one of the top 25 questions. Considering that regeneration and defense are interconnected facets of plant wound responses, it is reasonable to speculate that tomato mutants defective in the putative regeneration signal would show both compromised regeneration capacity and impaired defense responses. Based on this principle, the researchers identified a spr9 mutant that is defective in both wound-induced defense responses and regenerative responses. spr9 primarily affects local defense responses and abolishes the capacity of wound-induced callus formation and shoot regeneration, suggesting that the SPR9 gene plays a dual role in regulating wound-induced local defense and organ regeneration. Gene cloning studies revealed that the SPR9 gene encodes a precursor of a peptide. Depletion of SPR9 abolished the regenerative capacity of tomatoes, and overexpression of SPR9 resulted in enhanced regenerative capacity. Moreover, application of its peptide product dramatically increased regeneration capacity. Therefore, this peptide was designated as REGENERATION FACTOR1, or REF1. Further studies showed that REF1 is perceived by the receptor PORK1. When plant cells are injured, REF1 binds its receptor PORK1 to activate WIND1, a master regulator of wound-induced cellular reprogramming, thereby initiating regenerative responses.

3

🧠 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐂𝐚𝐫𝐞: 𝐓𝐡𝐞 𝐁𝐫𝐚𝐢𝐧 𝐍𝐚𝐭𝐫𝐢𝐮𝐫𝐞𝐭𝐢𝐜 𝐏𝐞𝐩𝐭𝐢𝐝𝐞 (𝐁𝐍𝐏) 𝐌𝐨𝐧𝐨𝐜𝐥𝐨𝐧𝐚𝐥 𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 🧠 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gQiqD4kp The Brain Natriuretic Peptide (BNP) Monoclonal Antibody Market is at the forefront of innovation in cardiac diagnostics and treatment. BNP is a crucial biomarker for heart failure, and monoclonal antibodies targeting BNP are transforming how we diagnose and manage this prevalent condition. 🌟 Key Highlights: Accurate Diagnostics: BNP monoclonal antibodies provide highly specific and sensitive tools for the diagnosis of heart failure, enabling early detection and more accurate monitoring of disease progression. Personalized Treatment: These antibodies are instrumental in guiding treatment decisions, allowing for more tailored and effective therapies that improve patient outcomes in heart failure management. Rapid Test Development: The use of BNP monoclonal antibodies in rapid diagnostic tests is revolutionizing point-of-care testing, providing immediate and reliable results that enhance clinical decision-making. 📈 Market Dynamics: Rising Prevalence of Heart Failure: With the increasing incidence of heart failure globally, the demand for accurate and reliable diagnostic tools like BNP monoclonal antibodies is on the rise, driving market growth. Advances in Monoclonal Antibody Technology: Continuous innovations in antibody engineering and production are enhancing the efficacy and accessibility of BNP monoclonal antibodies, making them a cornerstone in modern cardiac care. Regulatory Support: Growing support from regulatory bodies for the development and approval of BNP monoclonal antibody-based diagnostics is facilitating market expansion, ensuring that these critical tools are available to healthcare providers. #Company Sino Biological, Inc. Cell Signaling Technology, Inc. Bio-Techne OriGene Technologies, Inc. LSBio | LifeSpan BioSciences, Inc. Abbexa MyBioSource Biorbyt Creative Biolabs RayBiotech #Type Recombinant Non-recombinant #Application Flow Cytometry ELISA Western Blot Immunoprecipitation Immunofluorescence Other #CardiacCare #HeartFailure #BNPMonoclonalAntibodies #DiagnosticInnovation #PersonalizedMedicine #Healthcare #MedicalResearch #LinkedInPost

2